Screener
Travere Therapeutics, Inc. TVTX Total net product sales — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Travere Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:45 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001438533-26-000042
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Net product sales | $124,492 | $75,861 |
| License and collaboration revenue | 2,707 | 5,871 |
| Total revenue | 127,199 | 81,732 |
| Operating expenses: | ||
| Cost of goods sold | 1,950 | 4,679 |
| Research and development | 57,094 | 46,889 |
| Selling, general and administrative | 80,254 | 60,413 |
| Royalty expense | 24,816 | 12,425 |
Item 1. Financial Statements
FAQ
- What is Travere Therapeutics, Inc.'s total net product sales — total revenue?
- Travere Therapeutics, Inc. (TVTX) reported total net product sales — total revenue of $124.49M in Q1 2026.
- How has Travere Therapeutics, Inc.'s total net product sales — total revenue changed year-over-year?
- Travere Therapeutics, Inc.'s total net product sales — total revenue increased by 64.1% year-over-year, from $75.86M to $124.49M.
- What is the long-term trend for Travere Therapeutics, Inc.'s total net product sales — total revenue?
- Over 3 years (2022 to 2025), Travere Therapeutics, Inc.'s total net product sales — total revenue has grown at a 40.3% compound annual growth rate (CAGR), from $148.58M to $410.46M.
- What does total net product sales — total revenue mean?
- This metric represents the total revenue generated from the sale of pharmaceutical products after accounting for returns, rebates, and other sales deductions. It serves as a primary indicator of the commercial adoption and market penetration of the company's therapeutic portfolio. Tracking this figure allows investors to assess the growth trajectory and revenue-generating capacity of the company's core product offerings.
Ask your AI about Travere Therapeutics, Inc.'s total net product sales — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude